Pier 88 Investment Partners’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-90,935
| Closed | -$11M | – | 97 |
|
|
2023
Q1 | $11M | Sell |
90,935
-88,380
| -49% | -$10.7M | 2.66% | 18 |
|
|
2022
Q4 | $20.6M | Hold |
179,315
| – | – | 4.99% | 1 |
|
|
2022
Q3 | $18.2M | Buy |
179,315
+27,375
| +18% | +$2.78M | 4.33% | 4 |
|
|
2022
Q2 | $15.4M | Buy |
+151,940
| New | +$15.4M | 3.63% | 9 |
|
|
2022
Q1 | – | Sell |
-144,970
| Closed | -$16.6M | – | 100 |
|
|
2021
Q4 | $16.6M | Buy |
+144,970
| New | +$16.6M | 3.53% | 4 |
|
|
2020
Q4 | – | Sell |
-143,270
| Closed | -$16M | – | 129 |
|
|
2020
Q3 | $16M | Buy |
143,270
+56,690
| +65% | +$6.34M | 4.86% | 2 |
|
|
2020
Q2 | $9.07M | Buy |
+86,580
| New | +$9.07M | 2.58% | 11 |
|